Opendata, web and dolomites

ELDICO ED SIGNED

ELDICO ED, Shaping the Future of Crystallography - The First Pure Electron Diffraction Equipment for Nano-Crystallography

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ELDICO ED project word cloud

Explore the words cloud of the ELDICO ED project. It provides you a very rough idea of what is the project "ELDICO ED" about.

faster    18bn    opening    commercial    atomic    agrochemicals    2022    technique    segment    2024    500k    diffractometer    m2    perform    sub    diffraction    nano    quality    310m    crystallographers    drug    substances    structure    characterisation    compound    pure    crystalline    3m    employees    industry    particles    roi    electron    revenues    entering    sectors    overcoming    incorporating    84    scientific    ed    generating    structural    pharmaceutical    limited    patenting    forecast    crystal    unmeasurable    screened    market    annum    institutes    compounds    25    90    nanomaterials    eldico    pharma    size    shortening    hitherto    minimum    lower    techniques    impossible    conventional    approval    first    10    exclusively    saving    solid    overcomes    unlocking    designed    consuming    mu    micro    15    marketing    patent    instruments    time    discovery    libraries    company    regime    investigations    measured    ray    pending    3d    issue    drugs    11    limitations   

Project "ELDICO ED" data sheet

The following table provides information about the project.

Coordinator
ELDICO SCIENTIFIC AG 

Organization address
address: PARK INNOVAARE DELIVERY LAB
city: VILLIGEN
postcode: 5234
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELDICO SCIENTIFIC AG CH (VILLIGEN) coordinator 50˙000.00

Map

 Project objective

Crystal structure determination is still a key issue in pharmaceutical industry. Any compound requires its 3D atomic structure to become “fully characterized” for patenting and marketing approval. However, only the structure of the 10% of all crystalline substances can be determine. The reason: Conventional X-ray diffraction methods are limited because they require crystal of a minimum size of 10 x 10 μm2 and high quality to be measured, which are often time consuming or even impossible to produce. For example in drug discovery the 90% of known, but not fully characterized crystalline compounds, could be rapidly screened for their scientific or commercial potential. Although electron diffraction technique overcomes the limitations of current techniques and allows investigations on nano-crystalline systems, currently there are no commercial instruments dedicated exclusively to electron diffraction. With ELDICO ED we bring to the market the first equipment (patent pending) designed to perform electron diffraction. We offer an electron diffractometer for the analysis of solid compounds enabling crystallographers entering the sub-µm regime for structural analysis of hitherto unmeasurable nano-crystalline particles. That way, they produce important structural information faster, with better quality and at lower cost, overcoming the limitations of X-ray analysis. We are opening up a new market segment: Pure Electron Diffraction. Our technology will impact the pharma sector by unlocking the characterisation of the 500k existing potential new drugs in their libraries, shortening time-to-market by 10%, saving €9-18bn per annum for testing and increasing revenues of up to €310M per annum for every new drug that comes to the market. Similar impact in key sectors like research institutes, agrochemicals and Advanced Nanomaterials is expected. With ELDICO ED we forecast generating revenues of €25.3M (ROI: 11.84) and incorporating 15 employees to our company during 2022-2024

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ELDICO ED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ELDICO ED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More